S. 4070: Diabetes Foot Health Access and Modernization Act of 2026
This bill, known as the Diabetes Foot Health Access and Modernization Act of 2026, seeks to improve access to foot and ankle care for individuals with diabetes. It focuses on two main areas: recognition of podiatric physicians in Medicaid and updating Medicare requirements for diabetic footwear.
1. Recognizing Podiatric Physicians as Medicaid Providers
The bill proposes to amend the Social Security Act to officially recognize doctors of podiatric medicine as qualified physicians under the Medicaid program. This change aims to ensure that Medicaid beneficiaries have better access to necessary foot and ankle care services provided by these specialists.
The amendments would take effect for services provided on or after January 1, 2026. If a state needs to change its laws to comply with this new requirement, it will have until the first quarter after the conclusion of the regular legislative session to do so.
2. Modifying Medicare Documentation for Diabetic Shoes
The bill also aims to clarify the Medicare requirements for therapeutic shoes for individuals with diabetes. Currently, the law states that diabetic patients can receive special shoes if certain conditions are documented by a physician. The bill specifies that these shoes can be provided if:
- A physician documents that the patient has peripheral neuropathy or other relevant diabetic conditions.
- The physician confirms that the patient has a diabetes diagnosis and is under a comprehensive care plan.
- The physician attests that the patient requires these specialized shoes.
- The shoes are fitted by a qualified professional, which can include podiatrists among others.
These changes to Medicare documentation requirements will apply to items and services provided on or after January 1, 2028.
3. Importance of the Bill
This legislation aims to enhance the quality of care for diabetic patients, particularly regarding foot and ankle health, which is crucial in preventing serious complications like amputations due to diabetes-related issues. By improving access to care and resources, the bill seeks to address a significant area of healthcare that affects many individuals living with diabetes.
Relevant Companies
- MDT - Medtronic: This company manufactures diabetes care devices, including insulin pumps and therapeutic shoes, which may see changes in demand based on the bill's implementation.
- TSN - T1D for Life (the umbrella organization managing vital diabetes care services): Enhanced access for patients might lead to increased service utilization.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
2 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Mar. 12, 2026 | Introduced in Senate |
| Mar. 12, 2026 | Read twice and referred to the Committee on Finance. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.